Where does Widya Mulyasasmita work?

Widya Mulyasasmita is General Partner at BEVC and Board director at Triumvira Immunologics.

What check size does Widya Mulyasasmita write?

Widya Mulyasasmita typically writes checks of $25M – $60M.

Where did Widya Mulyasasmita go to school?

Widya Mulyasasmita studied at Stanford University (Ph.D., Bioengineering); University of California, Berkeley (B.S. Double Major, Bioenginering, Materials Science); Stanford University Graduate School of Business (Program in Innovation and Entrepreneurship (PRIE, now Ignite)).

Widya Mulyasasmita

Investor

General Partner at BEVC · General Partner at Bakar Entrepreneurship · Adjunct Lecturer, Bioengineering at Stanford University · Board director at Triumvira Immunologics

San Francisco, California

Writes $25M – $60M checks · typically $25M

Find your path to Widya

1,427 people in our graph share verified history with Widya — schools, employers, funds. One of them is your warm intro.

Scott AshworthunlockedWidya: together at magnus (2021)

×11Widya: together at B Capital Group

About

Widya Mulyasasmita is Co-Founder and Managing Partner at BEVC. He works as an investor, entrepreneur, and educator focused on supporting startups in the human and planetary health sectors.

Board director at Triumvira Immunologics

Intro paths

→

In turn, Widya can intro founders to Triumvira Immunologics's investors below.

Triumvira Immunologics's investors · 6

B Capital GroupManhattan Beach · $10M – $50M checks · since 2022 B4 Capital$10M – $50M checks Checkmate Capital Group LLCPasadena Leaps by BayerLeverkusen · since 2020 Northpond VenturesBethesda · $100K – $5M checks · since 2020 Oceanpine CapitalBeijing · since 2020

Experience

BEVCCo-Founder, Managing Partnercurrent2023 — presentSan Francisco Bay Area
Bakar Fellows ProgramAdvisory Board Membercurrent2024 — presentBerkeley, California, United States
Stanford UniversityAdjunct Lecturer, Bioengineeringcurrent2023 — presentStanford, California, United States
Partillion BioscienceFounding Advisorcurrent2020 — present
Triumvira Immunologics, Inc.Board of Directors2022 — 2023
Carlsmed, Inc.Investor and Board Observer2022 — 2023
B Capital GroupSr. Principal, Healthcare2021 — 2023San Francisco Bay Area
HotSpot Therapeutics, Inc.Investor and Board Observer2021 — 2023
OncoMyx TherapeuticsBoard of Directors2021 — 2023
Red Tree Venture CapitalVice President2020 — 2021San Francisco Bay Area
Magnus MedicalInvestor and Board Observer2020 — 2021
InterVenn BiosciencesChief Business Officer (Founding Team)2018 — 2020San Francisco Bay Area
Johnson & JohnsonDirector, New Ventures2015 — 2018South San Francisco, California
McKinsey & CompanyAssociate2013 — 2015Southeast Asia & US

Skills & more

Corporate Governance Excellence Program — Silicon Valley Executive Center

From Widya's professional profile.

Investments

Investor

Healthcare North America Growth StageOncoMyx Therapeutics Triumvira ImmunologicsViron

Per curated public sources.

What founders say

No founder feedback on Widya Mulyasasmita yet.

Leave your own feedback

Colleagues at BEVC

Carolyn Bertozzi, Ph.D.

Advisor at BEVC

Christina Curtis, Ph.D., MSc

Advisor at BEVC

David Schaffer, Ph.D.

Founding Advisor at BEVC

Greg Went, Ph.D.

Advisor at BEVC

Jennifer Doudna, Ph.D.

Frequently asked questions

Who is Widya Mulyasasmita?: Widya Mulyasasmita is Co-Founder and Managing Partner at BEVC. He works as an investor, entrepreneur, and educator focused on supporting startups in the human and planetary health sectors.
Where does Widya Mulyasasmita work?: Widya Mulyasasmita is General Partner at BEVC and Board director at Triumvira Immunologics.
What check size does Widya Mulyasasmita write?: Widya Mulyasasmita typically writes checks of $25M – $60M.
What companies has Widya Mulyasasmita invested in?: Investments tracked here include Healthcare North America Growth Stage, OncoMyx Therapeutics, Triumvira Immunologics, Viron.
Where did Widya Mulyasasmita go to school?: Widya Mulyasasmita studied at Stanford University (Ph.D., Bioengineering); University of California, Berkeley (B.S. Double Major, Bioenginering, Materials Science); Stanford University Graduate School of Business (Program in Innovation and Entrepreneurship (PRIE, now Ignite)).